No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs565844361 |
chr1:220919057-220919058 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs534714989 |
chr1:220919060-220919061 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs12058891 |
chr1:220919065-220919066 |
Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
4 |
rs577662178 |
chr1:220919066-220919067 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs189556775 |
chr1:220919082-220919083 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs6699853 |
chr1:220919164-220919165 |
Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
7 |
rs576357700 |
chr1:220919186-220919187 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs181562491 |
chr1:220919190-220919191 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs561962100 |
chr1:220919217-220919218 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs234223 |
chr1:220919232-220919233 |
Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
11 |
rs376086984 |
chr1:220919248-220919249 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs564471912 |
chr1:220919255-220919256 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs533459967 |
chr1:220919287-220919288 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs369671158 |
chr1:220919298-220919299 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs185801912 |
chr1:220919335-220919336 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs550873409 |
chr1:220919370-220919371 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs563669267 |
chr1:220919388-220919389 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs571059259 |
chr1:220919469-220919470 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs559965201 |
chr1:220919483-220919484 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs529216614 |
chr1:220919550-220919551 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs549256484 |
chr1:220919552-220919553 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs565883176 |
chr1:220919579-220919580 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs150564788 |
chr1:220919703-220919704 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs551544238 |
chr1:220919787-220919788 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs74139892 |
chr1:220919809-220919810 |
Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
26 |
rs537128088 |
chr1:220919838-220919839 |
Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs190612026 |
chr1:220919886-220919887 |
Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs533376290 |
chr1:220919913-220919914 |
Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs573268011 |
chr1:220919994-220919995 |
Bivalent Enhancer Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs546645289 |
chr1:220920047-220920048 |
Bivalent Enhancer Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs566574635 |
chr1:220920082-220920083 |
Bivalent Enhancer Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs12133663 |
chr1:220920083-220920084 |
Bivalent Enhancer Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
33 |
rs555441092 |
chr1:220920102-220920103 |
Bivalent Enhancer Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs111748558 |
chr1:220920142-220920143 |
Bivalent Enhancer Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs572404389 |
chr1:220920173-220920174 |
Bivalent Enhancer Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs569166798 |
chr1:220920174-220920175 |
Bivalent Enhancer Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs538166351 |
chr1:220920179-220920180 |
Bivalent Enhancer Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs564690056 |
chr1:220920224-220920225 |
Bivalent Enhancer Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs72472364 |
chr1:220920305-220920306 |
Bivalent Enhancer Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
40 |
rs112560055 |
chr1:220920339-220920340 |
Bivalent Enhancer Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs543860935 |
chr1:220920361-220920362 |
Bivalent Enhancer Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs12738566 |
chr1:220920374-220920375 |
Bivalent Enhancer Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
43 |
rs11800654 |
chr1:220920386-220920387 |
Bivalent Enhancer Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
44 |
rs369908343 |
chr1:220920405-220920406 |
Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs549394018 |
chr1:220920473-220920474 |
Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs182964758 |
chr1:220920492-220920493 |
Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs369883800 |
chr1:220920509-220920510 |
Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs371755147 |
chr1:220920517-220920518 |
Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs72472365 |
chr1:220920518-220920519 |
Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
50 |
rs571392952 |
chr1:220920520-220920521 |
Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|